FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

The Food and Drug Administration announced today that the label of Genentech Inc's psoriasis...

» read full story

October 17th, 2008 - 14:01

J&J Psoriasis Drug Meets Goal In Trial, Defeats Rival Enbrel

Johnson & Johnson unveiled Thursday results of a late-stage trial that showed its psoriasis...

» read full story

September 19th, 2008 - 14:11

Extra Caution Over Immunosuppressive Drugs

Drugs that work by suppressing the immune system to keep it from attacking the body, such...

» read full story

September 07th, 2008 - 16:56

Stronger Warnings For TNF Blocker Medications

Due to the fact that dozens of patients contracted severe fungal infections and died after taking...

» read full story

September 05th, 2008 - 22:06

FDA Orders Stronger Warnings on Arthritis Drugs

The Food and Drug Administration ordered stronger warnings about the risk of potentially deadly...

» read full story

September 05th, 2008 - 14:00

FDA Panel Backs New Drug for Moderate or Severe Rheumatoid Arthritis

By a 10-1 vote, a government advisory panel Tuesday backed Roche Holding AG's (RHHBY) drug Actemra...

» read full story

July 30th, 2008 - 19:10

Drug Combo Improves Rheumatoid Arthritis

A new study has found that a combination of two drugs, Enbrel and methotrexate, halts progression...

» read full story

July 16th, 2008 - 16:11

Enbrel Approved by FDA Panel for Kids with Psoriasis

A Food and Drug Administration advisory panel said Wednesday that wider use of Amgen Inc’s...

» read full story

June 20th, 2008 - 18:08

FDA Panel Recommends Amgen’s Enbrel For Kids

A FDA panel recommended that the psoriasis drug Enbrel should be approved for the treatment of the...

» read full story

June 19th, 2008 - 00:08

Rituxan Fails in Lupus Trial; Shares of Genentech and Biogen Drop

Shares of Genentech Inc. and Biogen Idec Inc. sagged on Tuesday after the companies said their...

» read full story

April 30th, 2008 - 15:38

FDA Panel Recommends New Arthritis Drug Approval

An FDA panel voted Tuesday 10 to 1 for the approval of a new drug that fights against rheumatoid...

» read full story

July 30th, 2008 - 20:09